Sunday 18 March 2018

Team Sky and Bradley Wiggins under suspicion - It is doping or not?

Some weeks ago, the Digital, Culture, Media and Sport (DCMS) select committee make public a report declaring that Team Sky and Bradley Wiggins would have used drugs allowed under anti-doping rules to enhance performance instead of just for medical need.

Concretaly, the report accuse Team Sky of had used the anty-inflammatory drug triamcionolone to prepare Bradley Wiggins for the 2012 Tour de France, that as all know, the britanian cyclist finally won.



Triamcionolone is a substance banned during competition under WADA rules, unless the athlete has a therapeutic use exemption (TUE),  but is permitted out of competition. 

According to the report, Bradley Wiggins would have taken this drug, the final day at 2011 Criterium du Dauphine. If this were true, Wiggins could be banned with two without compete and the loss of results achieved.

Apart from this drug, the report inform about the unclear use of other substances such a testosterone, salbutamol or fluimucil. Many of them drugs are consider as TUEs but Team Sky could have used it for enhance the performance of some his athletes, claiming a "medical use". On his behalf, Team Sky have strongly denied have used TUEs for anything other purpose that medical need.



At the moment, this issue is only a report without a reliable evidence, so that can not lead to any type of sanction, although is expected that UCI (Union Cycliste Internationale) open a investigation trying to clarify this matter in the following days.




No comments:

Post a Comment